Canada Unites With Netherlands, South Africa and Others to Host WCP 2026 for International Researchers, Healthcare Leaders and Pharmaceutical Innovators to Melbourne in MCEC: Here’s Everything You Need to Know Now

Written By: Minal Aditi Lakra

Minal Aditi Lakra

I graduated with a degree in Finance from the University of Calcutta and further strengthened my financial expertise by pursuing both the Chartered Accountancy (CA) and Certified Financial Planner (CFP) programs. Over the past decade, I have dedicated myself to building a career aligned with my long-term professional aspirations, combining analytical thinking with strategic communication. Currently, I work as a Public Relations Strategist at Travel And Tour World (TTW), a global travel media platform that connects industry leaders with travelers worldwide. My role involves translating the vision, insights, and innovations of tourism stakeholders—including governments, tourism boards, airlines, hospitality brands, and event organizers—into compelling stories that inform, inspire, and influence global travel audiences. Through strategic storytelling and media engagement, I help bridge the gap between industry leadership and evolving traveler expectations.

See Full Bio

July 15, 2026 5:51 PM

Image generated with Ai

Australia is preparing to welcome one of the world’s most influential scientific gatherings as the 20th World Congress of Basic and Clinical Pharmacology (WCP 2026) heads to the Melbourne Convention and Exhibition Centre (MCEC) from 12 to 17 July 2026. Organised under the auspices of the International Union of Basic and Clinical Pharmacology (IUPHAR) and hosted by the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), the congress is expected to bring together leading researchers, clinicians, pharmaceutical scientists and healthcare innovators from across the globe. More than a scientific conference, WCP 2026 underscores Australia’s growing stature as a destination capable of hosting world-class business events that stimulate tourism, strengthen international collaboration and reinforce Melbourne’s reputation as one of the Asia-Pacific region’s foremost meetings and events hubs.

For Australia’s visitor economy, international medical congresses such as WCP 2026 extend well beyond the conference halls. Delegates typically remain in host cities for several days, generating demand across hotels, restaurants, transport operators, cultural attractions and retail businesses while creating opportunities for networking, investment and future research partnerships. These events also enhance a destination’s international visibility, encouraging repeat business travel and reinforcing confidence among organisations considering Australia for future global meetings.

Hosting the congress at the Melbourne Convention and Exhibition Centre further highlights the venue’s strategic importance within Australia’s Meetings, Incentives, Conferences and Exhibitions (MICE) sector. Located on the banks of the Yarra River in the heart of Melbourne’s South Wharf precinct, MCEC has become one of the country’s premier convention venues since opening in 2009. The complex offers extensive exhibition halls, flexible meeting spaces and a large plenary theatre capable of accommodating thousands of delegates simultaneously. Its internationally recognised sustainability initiatives, including environmental certifications and energy-efficient operations, have strengthened its appeal among organisers seeking venues that align with increasingly important environmental, social and governance objectives.

The congress itself reflects the rapid evolution of pharmacology as advances in precision medicine, biotechnology, artificial intelligence and translational research continue to reshape healthcare worldwide. WCP 2026 will provide an international platform for discussions spanning drug discovery, clinical therapeutics, toxicology, pharmacogenomics and emerging medical technologies. Scientific sessions are expected to foster collaboration between academia, healthcare providers, regulatory authorities and the pharmaceutical industry, creating opportunities for knowledge exchange that extend far beyond the duration of the congress.

The organisers have already confirmed an internationally respected line-up of plenary and keynote speakers representing multiple continents. Among them are Professor Sharon Lewin AO from Australia’s Peter Doherty Institute, Professor Kelly Chibale of the University of Cape Town in South Africa, Professor Susan Howlett from Dalhousie University in Canada, Dr Nilima A. Kshirsagar of India, Professor Jesse Swen from Leiden University Medical Center in the Netherlands and Professor Glenn King from Australia’s Institute for Molecular Bioscience. Their expertise reflects the congress’s truly global scientific outlook and highlights the breadth of international collaboration shaping modern pharmacology.

Alongside the scientific programme, WCP 2026 will feature an international exhibition showcasing pharmaceutical manufacturers, biotechnology companies, clinical research organisations, laboratory technology providers, scientific publishers, academic institutions and innovators developing next-generation healthcare solutions. While the official exhibitor directory has yet to be released, the exhibition is expected to serve as an important marketplace where researchers, healthcare professionals and industry leaders can explore emerging technologies, establish partnerships and identify future commercial opportunities.

The congress also illustrates Australia’s continued investment in knowledge-driven tourism. Business events centred on medicine, biotechnology and scientific research typically attract highly qualified international delegates whose travel patterns differ from those of leisure visitors. Many extend their stay to experience the host destination, generating additional tourism expenditure while contributing to Melbourne’s hospitality sector. Hotels across the central business district and South Wharf are likely to benefit from increased occupancy, while airlines serving Melbourne are expected to see higher demand from international travellers arriving from North America, Europe, Asia and other parts of the Asia-Pacific region.

Melbourne’s accessibility further strengthens its attractiveness as a host destination. International delegates arriving through Melbourne Airport can reach the convention centre via public transport, airport shuttle services, taxis and rideshare options. The venue’s central location also places visitors within walking distance of numerous hotels, restaurants and cultural attractions, including the National Gallery of Victoria, Federation Square, the Royal Botanic Gardens and Melbourne’s renowned laneway dining precincts. Such proximity allows delegates to combine professional commitments with authentic local experiences, enhancing the overall visitor journey.

Australia’s broader tourism strategy also benefits from hosting globally recognised scientific congresses. Business events help diversify visitor markets by attracting professionals who travel throughout the year rather than solely during peak holiday seasons. This supports year-round hotel occupancy, strengthens aviation connectivity and encourages international organisations to view Australia as a competitive destination for future conferences. In an increasingly competitive global MICE landscape, the ability to host prestigious international congresses reinforces both Melbourne’s and Australia’s reputation for delivering sophisticated infrastructure, strong research capabilities and memorable visitor experiences.

What distinguishes WCP 2026 from many other international healthcare conferences is its interdisciplinary focus. By bringing together experts in basic pharmacology, clinical medicine, biotechnology, drug development and regulatory science under one roof, the congress creates opportunities for collaboration across sectors that rarely converge on such a scale. These interactions often accelerate scientific innovation while contributing to improvements in patient care and public health worldwide.

As preparations continue ahead of July 2026, WCP 2026 stands as more than another entry on Melbourne’s events calendar. It represents Australia’s commitment to scientific excellence, international collaboration and business events that generate meaningful economic and tourism outcomes. By welcoming researchers, clinicians and pharmaceutical innovators from around the world, Melbourne Convention and Exhibition Centre will once again demonstrate why it remains one of the Southern Hemisphere’s leading destinations for international meetings, while further strengthening Australia’s position within the global MICE and health sciences sectors.